Resectability and operative morbidity after chemotherapy in neuroblastoma patients with encasement of major visceral arteries

Journal of Pediatric Surgery

Volumn 46, Issue 1, 2011, Pages 103-107

  Rich, Barrie S ^a   McEvoy, Maureen P ^a   Kelly, Natasha E ^a   Oh, Edwin ^a   Abramson, Sara J ^a   Price, Anita P ^a   Cheung, Nai Kong V ^a   La Quaglia, Michael P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Neuroblastoma; Resectability; Vessel encasement

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CELIAC ARTERY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; GASTROINTESTINAL DISEASE; GENE AMPLIFICATION; HIGH RISK PATIENT; HUMAN; INFANT; INTERMEDIATE RISK PATIENT; KIDNEY ARTERY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEUROBLASTOMA; ONCOGENE C MYB; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROPERITONEAL ABSCESS; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SUPERIOR MESENTERIC ARTERY; SURGICAL RISK; SURVIVAL TIME; TREATMENT OUTCOME; VASCULAR DISEASE;

ABDOMINAL NEOPLASMS; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; ARTERIES; CELIAC ARTERY; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MESENTERIC ARTERY, SUPERIOR; NEOADJUVANT THERAPY; NEUROBLASTOMA; RENAL ARTERY; SURVIVAL RATE; TREATMENT OUTCOME; VISCERA;

EID: 78751514516     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.09.075     Document Type: Article

References (12)

1. La Quaglia M.P., Kushner B.H., and Su W. The impact of gross total resection on local control and survival in high-risk neuroblastoma J Pediatr Surg 39 2004 412 417
2. Kiely E.M. The surgical challenge of neuroblastoma J Pediatr Surg 29 1994 128 133
3. La Quaglia M.P. Surgical management of neuroblastoma Semin Pediatr Surg 10 2001 132 139
4. O'Neill J.A., Littman P., and Blitzer P. The role of surgery in localized neuroblastoma J Pediatr Surg 20 1985 708 712
5. von Schweinitz D., Hero B., and Berthold F. The impact of surgical radicality on outcome in childhood neuroblastoma Eur J Pediatr Surg 12 2002 402 409
6. Kushner B.H. Neuroblastoma: a disease requiring a multitude of imaging studies J Nucl Med 45 2004 1172 1188
7. Cecchetto G., Mosseri V., and De Bernardi B. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group J Clin Oncol 23 2005 8483 8489
8. Monclair T., Brodeur G.M., and Ambros P.F. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report J Clin Oncol 27 2009 298 303
9. Dindo D., Demartines N., and Clavien P.A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 2004 205 213
10. Matthay K.K., Villablanca J.G., and Seeger R.C. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group N Engl J Med 341 1999 1165 1173
11. Tarbell N.J., Guinan E.C., and Chin L. Renal insufficiency after total body irradiation for pediatric bone marrow transplantation Radiother Oncol 18 Suppl 1 1990 139 142
12. Canete A., Jovani C., and Lopez A. Surgical treatment for neuroblastoma: complications during 15 years' experience J Pediatr Surg 33 1998 1526 1530